» Articles » PMID: 21694610

Alcohol Consumption is Inversely Correlated with Insulin Resistance, Independent of Metabolic Syndrome Factors and Fatty Liver Diseases

Overview
Specialty Gastroenterology
Date 2011 Jun 23
PMID 21694610
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: The role of alcohol consumption in insulin resistance remains unclear. The aim of this study was to examine the association between alcohol consumption and insulin resistance in a large asymptomatic population.

Methods: A total of 2463 asymptomatic Japanese men aged 28 years or above undergoing a comprehensive health checkup including an oral glucose tolerance test between May 2007 and April 2010 were recruited. Participants positive for hepatitis B or C virus, abstinent alcoholics, those taking hepatotoxic drugs, those with chronic renal or hepatic failure, and those under treatment for metabolic disorders were excluded. Fatty liver was defined ultrasonographically. Visceral and subcutaneous adipose tissues were measured with computed tomography. The homeostasis model assessment of insulin resistance (HOMA-IR) score was determined to estimate insulin resistance. The association between alcohol consumption and HOMA-IR score was investigated with multivariate regression analysis.

Results: A total of 1902 participants were eligible for this cross-sectional survey. A significant difference in distribution of each drinking category was noted between 249 participants with insulin resistance (HOMA-IR ≥2.5) and 1653 participants without insulin resistance (HOMA-IR <2.5; P=0.001). Light (40 to 140 g/wk), moderate (140 to 280 g/wk), and heavy alcohol consumption was inversely associated with HOMA-IR scores (coefficients=-0.125, -0.127, and -0.162; P=0.007, 0.011, and 0.006, respectively) with multivariate analysis after adjusting for potential confounding variables, including visceral and subcutaneous adipose tissues, metabolic profiles, fatty liver, and liver enzyme activities.

Conclusions: Alcohol consumption was inversely associated with insulin resistance, independent of central obesity, metabolic profiles, and fatty liver diseases.

Citing Articles

Alcohol and Metabolic-associated Fatty Liver Disease.

Sun F, Wang B J Clin Transl Hepatol. 2021; 9(5):719-730.

PMID: 34722187 PMC: 8516839. DOI: 10.14218/JCTH.2021.00173.


Association of dietary patterns with the newly diagnosed diabetes mellitus and central obesity: a community based cross-sectional study.

Yin X, Chen Y, Lu W, Jin T, Li L Nutr Diabetes. 2020; 10(1):16.

PMID: 32499520 PMC: 7272454. DOI: 10.1038/s41387-020-0120-y.


Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?.

Petroni M, Brodosi L, Marchignoli F, Musio A, Marchesini G Nutrients. 2019; 11(12).

PMID: 31847199 PMC: 6950084. DOI: 10.3390/nu11123048.


Ethanol-Induced Hepatic Insulin Resistance is Ameliorated by Methyl Ferulic Acid Through the PI3K/AKT Signaling Pathway.

Cheng Q, Li Y, Yang C, Zhong Y, Li L Front Pharmacol. 2019; 10:949.

PMID: 31555134 PMC: 6726842. DOI: 10.3389/fphar.2019.00949.


Alcohol consumption and its interaction with genetic variants are strongly associated with the risk of type 2 diabetes: a prospective cohort study.

Yu H, Wang T, Zhang R, Yan J, Jiang F, Li S Nutr Metab (Lond). 2019; 16:64.

PMID: 31528183 PMC: 6743143. DOI: 10.1186/s12986-019-0396-x.